Pharmafile Logo
Pharmafocus logo
Advanced Search
reuters_dado_ruvic

Novavax secures deal with New Zealand for 10.7m doses of COVID-19 vaccine

December 17, 2020
Sales and Marketing COVID-19, Novavax, Vaccine

Novavax has announced an Advance Purchase Agreement with New Zealand for the purchase of 10.7 million doses of NVX-CoV2373, the …

News

FDA says Pfizer vaccine vials contain extra doses, boosting US supply

December 17, 2020
Sales and Marketing COVID-19, FDA, Pfizer, Vaccine

The FDA has announced that extra doses contained in Pfizer COVID-19 vaccine vials could expand America’s supply of the jab …

News
novartis_outside_1

Novartis acquires Cadent Therapeutics in potential $770 million deal

December 17, 2020
Sales and Marketing Cadent, Novartis, acquisition

Novartis has sealed an agreement with Cadent Therapeutics to acquire the firm in a deal worth up to $770 million, …

News
nice_new_london_office_internal_3_web

NICE recommends Novartis’ Beovu for wet age-related macular degeneration

December 16, 2020
Research and Development NICE, Novartis, wet AMD Beovu

NICE has published its final appraisal of Novartis’ Beovu (brolucizumab), recommending that the drug be made available via the NHS …

News

Quarter of the world may not access COVID-19 vaccine until 2022

December 16, 2020
Research and Development COVID-19, Vaccine

Almost a quarter of the world’s population may not have access to a COVID-19 vaccine until 2022, according to a …

News
abbvie_0

AbbVie buys COVID-19 antibody licence from Harbour BioMed

December 16, 2020
Research and Development AbbVie, COVID-19, Harbour BioMed, antibody

Harbour BioMed (HBM) and Utrecht University (UU) have announced that their fully human, SARS-CoV-2 neutralising antibody 47D11 and programme, has …

News
dw-anzcxqaqavhl

FDA panel backs Novartis’ Entresto for different form of heart disease

December 16, 2020
Research and Development FDA, Novartis, heart failure

Novartis’ heart failure drug Entresto has received recommendation from the FDA’s Cardiovascular and Renal Drugs Advisory Committee for use in …

News
lilly_building_with_american_flag_web

Eli Lilly scoops up gene therapy specialist Prevail Therapeutics for a potential $1.04bn

December 16, 2020
Research and Development, Sales and Marketing Eli Lilly, Prevail, acquisition

Eli Lilly has struck a deal to acquire Prevail Therapeutics in a transaction that could be valued at up to …

News

How COVID-19 is affecting diabetics and their access to insulin in America

December 15, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Diabetic patients face daily challenges of treatment access and treatment management, so 2020 has been a particularly challenging year. Conor …

Feature
astrazeneca_building_white

EMA panel recommends label extension of AstraZeneca’s Imfinzi in non-small cell lung cancer

December 15, 2020
Manufacturing and Production, Sales and Marketing AstraZeneca, Europe, Imfinzi, NSCLC

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has backed a new dosing regimen of AstraZeneca’s …

News
3500

UAE rolls out Sinopharm COVID-19 vaccine amid conflicting reports of efficacy

December 15, 2020
Manufacturing and Production, Research and Development COVID-19, China, Sinopharm, UAE, coronavirus

The United Arab Emirates has begun rolling out Sinopharm’s COVID-19 vaccine in its capital Abu Dhabi, despite claims that numerous …

News
reuters_-_tatyana_makeyeva_1

Final control point analysis shows 90% efficacy for Russia’s Sputnik V COVID-19 vaccine

December 15, 2020
Manufacturing and Production, Research and Development COVID-19, Sputnik V, Vaccine

Efficacy data have been revealed from the final control point data analysis for Russia’s Sputnik V COVID-19 vaccine, showing the …

News
1920px-city_of_london_skyline_from_london_city_hall_-_sept_2015_-_crop

New coronavirus strain identified in the UK

December 15, 2020
Manufacturing and Production, Research and Development COVID-19, UK, coronavirus, vaccines

A new variant of coronavirus has been identified in the UK, and is growing faster in some parts of England, …

News
image_3

PPAs – Ready to make a long-term commitment to zero carbon?

December 14, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Energy, sustainability

As an industry that consumes a large amount of energy, the pressure is on for the pharmaceutical sector to achieve …

News

PPAs – Ready to make a long-term commitment to zero carbon?

December 14, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Energy, sustainability

As an industry that consumes a large amount of energy, the pressure is on for the pharmaceutical sector to achieve …

News
Press release
fdaoutsideweb

FDA issues emergency use authorisation for Pfizer-BioNTech vaccine

December 14, 2020
Sales and Marketing COVID-19, FDA, US, Vaccine

The US Food and Drug Administration has approved the Pfizer-BioNTech COVID-19 vaccine for emergency use in those aged 16 and …

News
shutterstock_273326141

AstraZeneca to buy Alexion in $39 billion deal

December 14, 2020
Sales and Marketing Alexion, AstraZeneca, merger

British-Swedish AstraZeneca is set to acquire American biopharmaceutical company Alexion for $39 billion, in a move that will see a …

News
bavencio_merck_large

Pfizer and Merck KGaA secure CHMP recommendation for Bavencio in Europe for first-line maintenance of urothelial carcinoma

December 14, 2020
Sales and Marketing Bavencio, CHMP, EMA, Merck, Pfizer, pharma, urothelial carcinoma

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has given its recommendation for …

News
european_commission

European approval for AstraZeneca’s Trixeo Aerospace in moderate to severe COPD

December 14, 2020
Sales and Marketing AstraZeneca, COPD, EMA, Europe, Trixeo Aerosphere

The European Medicines Agency (EMA) has announced the approval of AstraZeneca’s Trixeo Aerosphere (formoterol fumarate/glycopyrronium bromide/budesonide) in the European Union …

News
shutterstock_95714119

Novartis and Incyte’s ruxolitinib fails to show benefit in COVID-19 at Phase 3

December 14, 2020
Research and Development, Sales and Marketing COVID-19, Incyte, Novartis

Novartis has unveiled that its JAK 1/2 tyrosine kinase inhibitor ruxolitinib fell short of its main efficacy goal in the …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026